Bliss GVS Pharma Board Approves Two ESOP Schemes For 73.5 Lakh Shares

Board approved Senior Executive ESOP (26.5L shares, ~2.49%) and Employee ESOP (47L shares, ~4.42%) at Rs10 via fresh shares, subject to shareholder approval. First substantive move under new control after board reshuffle; large retention push with MD vacant and strategy plan awaited, step change from prior small ESOP allotments. Combined ~6.91% dilution if fully exercised at deep discount; grantees, vesting timelines and P&L cost undisclosed; overhang till shareholder vote.